Nevro Corp. engages in the development of medical devices. The company is headquartered in Redwood City, California and currently employs 1,099 full-time employees. The firm is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. The company has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories AtriCure Inc Cryoport Inc Glaukos Corp Integer Holdings Corp NUVASIVE INC Paragon 28, Inc. Procept Biorobotics Corp Treace Medical Concepts, Inc Transmedics Group Inc